Survival analysis after resection of metastatic disease followed by peptide vaccines in patients with Stage IV melanoma Academic Article uri icon

Overview

MeSH Major

  • Cancer Vaccines
  • Lymph Node Excision
  • Melanoma
  • Vaccines, Subunit

abstract

  • In selected patients with AJCC Stage IV melanoma, resection of metastatic disease followed by vaccine therapy can result in long-term survival.

publication date

  • March 15, 2006

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1002/cncr.21748

PubMed ID

  • 16475151

Additional Document Info

start page

  • 1353

end page

  • 7

volume

  • 106

number

  • 6